Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Mühlemann

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
The Lancet. Microbe|April 13, 2021
Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation studyVictor M Corman, Verena Claudia Haage, Tobias Bleicker, et al.
Influenza and Other Respiratory Viruses|October 6, 2023
The effectiveness of primary series CoronaVac vaccine in preventing COVID-19 illness: A prospective cohort study among healthcare workers in Azerbaijan, May-November 2021Mark A Katz, Madelyn Yiseth Rojas Castro, Nabil Seyidov, et al.
Open Forum Infectious Diseases|October 27, 2023
Primary Series and Booster Coronavirus Disease 2019 Vaccine Effectiveness in a Cohort of Healthcare Workers in Albania During a BA.1 and BA.2 Variant Period, January-May 2022Iris Finci, Madelyn Yiseth Rojas Castro, Iris Hasibra, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 17, 2021
Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational studyBarbara Mühlemann, Charlotte Thibeault, David Hillus, et al.
Genome Biology|December 12, 2022
Pathogen genomics study of an early medieval community in Germany reveals extensive co-infectionsJoanna H Bonczarowska, Julian Susat, Barbara Mühlemann, et al.
Microorganisms|April 30, 2021
Surveillance of SARS-CoV-2 in Frankfurt am Main from October to December 2020 Reveals High Viral Diversity Including Spike Mutation N501Y in B.1.1.70 and B.1.1.7Marek Widera, Barbara Mühlemann, Victor M Corman, et al.
Emerging Infectious Diseases|December 6, 2024
Ongoing Evolution of Middle East Respiratory Syndrome Coronavirus, Saudi Arabia, 2023-2024Ahmed M Hassan, Barbara Mühlemann, Tagreed L Al-Subhi, et al.
Virus Evolution|April 24, 2023
Non-structural genes of novel lemur adenoviruses reveal codivergence of virus and hostTalitha Veith, Tobias Bleicker, Monika Eschbach-Bludau, et al.
Science (New York, N.Y.)|May 26, 2021
Estimating infectiousness throughout SARS-CoV-2 infection courseTerry C Jones, Guido Biele, Barbara Mühlemann, et al.
Plos Pathogens|September 25, 2023
Pharmacological inhibition of bromodomain and extra-terminal proteins induces an NRF-2-mediated antiviral state that is subverted by SARS-CoV-2 infectionBaxolele Mhlekude, Dylan Postmus, Saskia Stenzel, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
The Lancet. Microbe|April 13, 2021
Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation studyVictor M Corman, Verena Claudia Haage, Tobias Bleicker, et al.
Influenza and Other Respiratory Viruses|October 6, 2023
The effectiveness of primary series CoronaVac vaccine in preventing COVID-19 illness: A prospective cohort study among healthcare workers in Azerbaijan, May-November 2021Mark A Katz, Madelyn Yiseth Rojas Castro, Nabil Seyidov, et al.
Open Forum Infectious Diseases|October 27, 2023
Primary Series and Booster Coronavirus Disease 2019 Vaccine Effectiveness in a Cohort of Healthcare Workers in Albania During a BA.1 and BA.2 Variant Period, January-May 2022Iris Finci, Madelyn Yiseth Rojas Castro, Iris Hasibra, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 17, 2021
Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational studyBarbara Mühlemann, Charlotte Thibeault, David Hillus, et al.
Genome Biology|December 12, 2022
Pathogen genomics study of an early medieval community in Germany reveals extensive co-infectionsJoanna H Bonczarowska, Julian Susat, Barbara Mühlemann, et al.
Microorganisms|April 30, 2021
Surveillance of SARS-CoV-2 in Frankfurt am Main from October to December 2020 Reveals High Viral Diversity Including Spike Mutation N501Y in B.1.1.70 and B.1.1.7Marek Widera, Barbara Mühlemann, Victor M Corman, et al.
Emerging Infectious Diseases|December 6, 2024
Ongoing Evolution of Middle East Respiratory Syndrome Coronavirus, Saudi Arabia, 2023-2024Ahmed M Hassan, Barbara Mühlemann, Tagreed L Al-Subhi, et al.
Virus Evolution|April 24, 2023
Non-structural genes of novel lemur adenoviruses reveal codivergence of virus and hostTalitha Veith, Tobias Bleicker, Monika Eschbach-Bludau, et al.
Science (New York, N.Y.)|May 26, 2021
Estimating infectiousness throughout SARS-CoV-2 infection courseTerry C Jones, Guido Biele, Barbara Mühlemann, et al.
Plos Pathogens|September 25, 2023
Pharmacological inhibition of bromodomain and extra-terminal proteins induces an NRF-2-mediated antiviral state that is subverted by SARS-CoV-2 infectionBaxolele Mhlekude, Dylan Postmus, Saskia Stenzel, et al.
Pageof 5